[1]顾涛颖,石洪成.放射性药物治疗肿瘤骨转移性骨痛的作用[J].国际放射医学核医学杂志,2010,34(2):88-90.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
 GU Tao-ying,SHI Hong-cheng.The use of radiopharmaceuticals for metastatic bone pain in cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):88-90.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
点击复制

放射性药物治疗肿瘤骨转移性骨痛的作用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
34
期数:
2010年第2期
页码:
88-90
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The use of radiopharmaceuticals for metastatic bone pain in cancer patients
作者:
顾涛颖 石洪成
上海复旦大学附属中山医院核医学科, 200032
Author(s):
GU Tao-ying SHI Hong-cheng
Department of Nuclear Medicine, Zhongshan Hospital of Fudan University, Shanghai 200032, China
关键词:
肿瘤转移疼痛顽固性放射性药物
Keywords:
Neoplasms metastasisPainintractableRadiopharmaceuticals
DOI:
10.3760/cma.j.issn.1673-4114.2010.02.006
摘要:
恶性肿瘤会发生骨转移,早期发现骨转移可以预防骨相关事件的发生,改善预后。用于治疗转移性骨痛的放射性核素有5大类:89Sr、153Sm、186Re/188Re、117Sn、31P。放射性药物治疗转移性骨痛的效果较好,尤其适用于成骨性或混合型骨转移。放射性药物联合双磷酸盐药物治疗广泛转移性骨痛效果显着,优于两者的单独使用,明显改善患者生存质量。
Abstract:
Malignant tumors presented with bone metastasis. Earlier detection of bone metastasis can prevent skeletal-related events and improve prognosis. Common radiopharmaceuticals for bone metastasis include 89Sr、153Sm、186Re/188Re、117Sn and 31P the effectiveness of them is identified, especially for osteoplastic metastasis and mixed metastasis. Radiopharmaceuticals combined with bisphosphonates for extensive painful bone metastasis is significantly more effective than using either of them alone, in improving the life quality of cancer patients.

参考文献/References:

[1] Lam MG,de Klerk JM,van Rijk PP,et al.Bone seeking radiophar-maceuticals for palliation of pain in cancer patients with osseous metastases.Anti cancer Agents Med Chem,2007,7(4):381-397.
[2] Costa L.Bisphosphonates:reducing the risk of skeletal complica-tions from bone metastasis.Breast,2007,16(Suppl 3):S16-S20.
[3] Choong PF.The molecular basis of skeletal metastases.Clin Oithop Relat Res,2003,415(Suppl):S19-S31.
[4] Coleman RE,Seaman JJ.Hie role of zoledronic acid in cancer:clinical studies in the treatment and prevention of bone metastases.Semin Oncol,2001,28(2 Suppl 6):11-16.
[5] Bodei L,Lam M,Chiesa G,et al.EANM procedure guideline for treatment of refractory metastatic bone pain.Eur J Nucl Med Mol Imaging,2008,35(10):1934-1940.
[6] Gkialas I,Iordanidou L,Calanakis I,et al.The use of radioisotopes for palliation of metastatic bone pain.J BUON,2008,13(2):177-183.
[7] Bauman G,Charette M,Reid R,et al.Radiopharmaceuticals for the palliation of painful metastasis-a systemic review.Radiother Oncol,2005,75(3):258-270.
[8] Tripathi M,Singhal T,Chandrasekhar N,et al. Samarium-153 ethylene-diamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases,Indian J Cancer,2006,43(2):86-92.
[9] Baczyk M,Czepczyñski R,Milecki P,et al.89Sr versus 153Sm-EDTMP:comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.Nucl Med Commun,2007,28(4):245-250.
[10] Liepe K,Kotzerke J.A comparative study of 188Re-HEDP,186Re-HEDP,153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.Nucl Med Commun,2007,28(8):623-630.
[11] Amato RJ,Hemandez-McClain J,Henary H.Bone-targeted therapy:phase II study of strontium-89 in combination with alternating weekly chemohortnonal therapies for patients with advanced androgen-independent prostate cancer.Am J Clin Oncol,2008,31(6):532-538.
[12] Pagliaro LC,Delpassand ES,Williams D,et al.A phase I/Ⅱ study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases.Cancer,2003,97(12):2988-2994.
[13] Finlay IG,Mason MD,Shelley M.Radioisotopes for the palliation of metastatic bone cancer:a systematic review.Lancet Oncol,2005,6(6):392-400.
[14] Lewington VJ.Bone-seeking radionuclides for therapy.J Nucl Med,2005,46(Suppl 1):38S-47S.
[15] Storto G,Klain M,Paone G,et al.Combined therapy of 89Sr-and zoledronic acid in patients with painful bone metastases.Bone,2006,39(1):35-41.
[16] Koutsikos J,Leondi A.Treatment efficacy of combined bipfaospho-nates and 186Re-HEDP treatment in cancer patients with bone metastases.Eur J Nucl Med Mol Imaging,2008,35(7):1392-1393.
[17] 梁九根,蒋宁一,杜建强,等.188Re-羟乙基二膦酸与帕米膦酸二钠联合治疗乳腺癌骨转移的临床价值.中华肿瘤杂志,2005,27(3):180-182.
[18] Vassiliou V,Bmland O,Janjan N,et al.Combining systemic bis-phosphonates with palliative external beam radiotherapy or bone-targeted radionuclide therapy:interactions and effectiveness.Clin Oncol,2009,21(9):665-667.
[19] Costa L. Bisphosphonates:reducing the of risk skeletal complications from bone metastasis.Breast,2007,16(Suppl 3):S16-S20.
[20] Valachis A,Polyzos NP,Georgoulias V,el al.Lack of evidence for fracture prevention in early breast cancer bisphos-phonate trials:a meta-analysis.Gynecol Oncol,2010,117(1):139-145.

相似文献/References:

[1]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
 Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[2]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
 Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[3]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
 Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[4]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
 Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[5]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
 Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[6]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
 Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[7]凌彩霞,肖国有.SPECT/CT骨断层显像及在恶性肿瘤骨转移诊断中的临床价值[J].国际放射医学核医学杂志,2014,38(4):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
 Ling Caixia,Xiao Guoyou.The clinical value of SPECT/CT bone tomography in the diagnosis of malignant tumor metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
[8]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
 Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[9]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
 Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[10]赵红光,徐松柏,关锋,等.骶骨脊索瘤伴肺转移18F-FDG PET/CT显像一例[J].国际放射医学核医学杂志,2013,37(2):128.[doi:10.3760/cma.j.issn.1673-4114.2013.02.017]

备注/Memo

备注/Memo:
收稿日期:2010-02-02。
通讯作者:石洪成(E-mail:suminismile@sina.com)
更新日期/Last Update: 1900-01-01